Amicus Therapeutics, Inc.
Overview
Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering innovative medicines for the rare disease community. The company's primary platform involves the development of advanced therapies to address a wide range of rare conditions, with a strong emphasis on lysosomal storage disorders.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Amicus Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Amicus Therapeutics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.